1. Home
  2. UFPT vs LGND Comparison

UFPT vs LGND Comparison

Compare UFPT & LGND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UFPT
  • LGND
  • Stock Information
  • Founded
  • UFPT 1963
  • LGND 1987
  • Country
  • UFPT United States
  • LGND United States
  • Employees
  • UFPT N/A
  • LGND N/A
  • Industry
  • UFPT Medical/Dental Instruments
  • LGND Biotechnology: Pharmaceutical Preparations
  • Sector
  • UFPT Health Care
  • LGND Health Care
  • Exchange
  • UFPT Nasdaq
  • LGND Nasdaq
  • Market Cap
  • UFPT 1.6B
  • LGND 2.1B
  • IPO Year
  • UFPT 1993
  • LGND 1992
  • Fundamental
  • Price
  • UFPT $236.48
  • LGND $104.48
  • Analyst Decision
  • UFPT Buy
  • LGND Strong Buy
  • Analyst Count
  • UFPT 2
  • LGND 8
  • Target Price
  • UFPT $392.00
  • LGND $144.71
  • AVG Volume (30 Days)
  • UFPT 122.8K
  • LGND 102.0K
  • Earning Date
  • UFPT 05-06-2025
  • LGND 05-08-2025
  • Dividend Yield
  • UFPT N/A
  • LGND N/A
  • EPS Growth
  • UFPT 31.41
  • LGND N/A
  • EPS
  • UFPT 8.15
  • LGND N/A
  • Revenue
  • UFPT $547,560,000.00
  • LGND $181,488,000.00
  • Revenue This Year
  • UFPT $18.91
  • LGND $16.47
  • Revenue Next Year
  • UFPT $7.77
  • LGND $19.44
  • P/E Ratio
  • UFPT $28.90
  • LGND N/A
  • Revenue Growth
  • UFPT 34.43
  • LGND 53.40
  • 52 Week Low
  • UFPT $178.26
  • LGND $72.61
  • 52 Week High
  • UFPT $366.41
  • LGND $129.90
  • Technical
  • Relative Strength Index (RSI)
  • UFPT 65.34
  • LGND 46.11
  • Support Level
  • UFPT $193.13
  • LGND $99.24
  • Resistance Level
  • UFPT $225.43
  • LGND $107.37
  • Average True Range (ATR)
  • UFPT 11.98
  • LGND 4.05
  • MACD
  • UFPT 3.55
  • LGND -0.33
  • Stochastic Oscillator
  • UFPT 98.70
  • LGND 39.37

About UFPT UFP Technologies Inc.

UFP Technologies Inc is a designer and custom manufacturer of components, subassemblies, products, and packaging utilizing specialized foams, films, and plastics for the medical market. The company manufactures its products by converting raw materials using laminating, molding, radio frequency and impulse welding, and fabricating manufacturing techniques. It is an important link in the medical device supply chain and a valued outsource partner to many of the top medical device manufacturers in the world. The company's single-use and single-patient devices and components are used in a wide range of medical devices, disposable wound care products, infection prevention, minimally invasive surgery, wearables, orthopedic soft goods, and orthopedic implant packaging.

About LGND Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.

Share on Social Networks: